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ABSTRACT. 
One of the lajor features of herpesvirus infections of minis is latency. Fro· tiie to tiie detectable 
episodes of virus shedding lay occur, both apparently spontaneously and as a result of certain endogenous 
and exogenous stiiuli, A nuiber of experimental systets have been investigated to study the phenomenon of 
latency and recrudescence, lainly using herpes siiplex virus infection in the louse eodel. Honever, there 
are a nuiber of other aniial species that can be studied «here the herpesvirus is in its owi natural 
host-virus systei. Tuo such exaiples, the cat and pigeon herpesviruses, are described here. Both of these 
produce a latent infection in their hosts, and can be reactivated under «ell-defined conditions either as a 
result of natural, physiological stresses, or fro· lore artificial stiiuli. As a result of these 
observations, sote conclusions are drawn about the biological role of latency. 
INTRODUCTION. 
One o-f t h e m a j o r - f e a t u r e s o-f h e r p e s v i r u s i n f e c t i o n s o-f 
a n i m a l s i s t h e phenomenon o-f l a t e n c y . L a t e n c y may be d e f i n e d a s 
t h e masked p e r s i s t e n c e o-f v i r u s i n t h e h o s t , so t h a t i t c a n n o t 
be d e t e c t e d b y c o n v e n t i o n a l v i r o l o g i c a l t e c h n i q u e s . From t i m e 
t o t i m e , h o w e v e r , d e t e c t a b l e e p i s o d e s o-f v i r u s s h e d d i n g 
( r e — e x c r e t i o n ) may o c c u r , b o t h a p p a r e n t l y s p o n t a n e o u s l y and a s 
a r e s u l t o-f c e r t a i n e n d o g e n o u s o r e x o g e n o u s s t i m u l i , and w h i c h 
may o r may n o t be a c c o m p a n i e d by c l i n i c a l s i g n s 
( r e c r u d e s c e n c e ) . T h u s i n p e o p l e , h e r p e s s i m p l e x v i r u s (HSV) 
r e c r u d e s c e n c e t e n d s t o o c c u r a f t e r p h y s i o l o g i c a l s t r e s s e s s u c h 
a s m e n s t r u a t i o n o r p y r e x i a ( R o i z m a n , 1 9 6 5 ) , and i n a n i m a l 
h e r p e s v i r u s i n f e c t i o n s s t r e s s e s s u c h a s a c h a n g e o f h o u s i n g o r 
t h e r e p r o d u c t i v e p e r i o d may i n d u c e v i r u s r e — e x c r e t i o n ( G a s k e l l 
and P o v e y , 1 9 7 7 , 1 9 8 2 ; M c F e r r a n e t a l . , 1 9 8 4 ; V i n d e v o g e l e t 
a l . , 1 9 B 5 ) . R e - e x c r e t i o n may a l s o be s t i m u l a t e d i n many s p e c i e s 
by means o f c o r t i c o s t e r o i d o r o t h e r i m m u n o — s u p p r e s s i v e 
t r e a t m e n t ( S h e f f y and D a v i e s , 1 9 7 2 ; G a s k e l l and P o v e y , 1 9 7 3 ; 
V i n d e v o g e l e t a l . , 1 9 8 0 b ; W i t t m a n n n e t a l . , 1 9 8 2 ) , t h o u g h t h e 
e x a c t mechan ism o f t h i s i s u n k n o w n . 
A number o f e x p e r i m e n t a l s y s t e m s h a v e b e e n i n v e s t i g a t e d i n 
o r d e r t o s t u d y t h e phenomenon o f l a t e n c y and r e c r u d e s c e n c e . T h e 
m a j o r i t y h a v e c o n c e n t r a t e d on human HSV i n f e c t i o n i n t h e mouse 
m o d e l , t h e mouse b e i n g c h o s e n n o t o n l y b e c a u s e o f c o n v e n i e n c e 
and o u r i m m u n o l o g i c a l k n o w l e d g e o f t h e h o s t , b u t a l s o b e c a u s e 
o f i t s l o w b a c k g r o u n d l e v e l o f s p o n t a n e o u s r e a c t i v a t i o n 
c o m p a r e d t o some o t h e r l a b o r a t o r y s p e c i e s ( S e k i z a w a e t a l . , 
1 9 8 0 ; Openshaw, 1 9 8 4 ) . A v a r i e t y o f m e t h o d s h a v e b e e n u s e d i n 
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the mouse to induce re-excretion, including corticosteroid 
treatment (Underwood and Weed, 1974), cyclophosphamide (Kurata 
et al., 1978), skin trauma (Hill et al., 1978) and ultraviolet 
light (Blyth et al., 1976). Possible mechanisms for the 
establishment, maintenance and control of HSV latency, 
particularly with respect to experi menata l findings on the mouse 
model, have been discussed by Blyth and Hill (1984). 
However, there are a number of other animal species that 
may be studied where the herpesvirus is in its own natural 
host-virus system. Studying latency in the proper animal 
species reduces errors that may arise as a result of 
experimental contrivance, for the same herpesvirus infection 
may give different results both within and between species. In 
veterinary medicine compared to human medicine however, virus 
re-excretion or shedding ("reactivation" in the mouse model) is 
considered more important than recrudescent disease, for it is 
the epidemiological implications of the re—excreting animal in 
a herd or group that are important, rather than recrudescent 
disease in the individual. 
This paper describes two herpesvirus infections of 
animals; Felid herpesvirus 1 (FHV 1) and Pigeon herpesvirus 1 
(PHV 1). Both of these produce a latent infection in their hosts, 
and can be reactivated under well-defined conditions either as 
a result of natural, physiological stresses, or from more 
artificial stimuli. As a result of these observations, some 
conclusions are drawn about the biological role of latency. 
EELID_HERPESyiRyS_l_iFHV_l!. 
FHV 1 is an alphaherpesvirus of cats. It is a respiratory 
pathogen producing a disease known as feline viral 
rhinotracheitis. In contrast to the broader host range of some 
other herpesviruses such as ADV or HSV, the virus only affects 
domestic cats and other Felidae (Povey, 1979). All isolates so 
far examined from many parts of the world show antigenic 
homogeneity on the basis of conventional serological 
cross-neutralisation tests (Crandell et al., I960; Bittle et 
al., 1960; Johnson and Thomas, 1966), although more refined 
serological techniques have not been used. Recent work using 
restriction enzyme analysis of the viral DNA has confirmed this 
high degree of similarity between strains which in general is 
reflected in the relatively uniform'biological behaviour of 
isolates (Hermann et al., 1984). However strains of modified 
virulence do exist, having been produced in recent years for 
vaccines (Slater and York, 1976; Davies and Beckenhauer, 1976; 
Bittle and Rubic, 1975). 
No serological relationship has been demonstrated between 
FHV 1 and a second feline herpesvirus associated with 
urolithiasis (Fabricant and Gillespie, 1971), nor with several 
other alphaherpesvirus of other species (Povey, 1979). 
FHV 1 is highly infectious to susceptible cats, infection 
occurring via the intranasal, oral or conjunctival routes. In 
the acute phase of the disease, the major sites of virus 
replication are in the nasal septum, turbinates, nasopharynx 
and tonsils; conjunctivae, mandibular lymph nodes and trachea 
are also often involved (Crandell et al., 1961; Gaskell and 
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Povey, 1979a). A viraemia has only rarely been reported. A 
possible genital tropism has been investigated experimentally, 
but is not thought to be of significance under natural 
conditions (Bittle and Peckham, 1971; Hoover and Griesemer, 
1971). 
The virus is a comparatively labile virus, surviving under 
typical external environment conditions for less than a day 
(Povey and Johnson, 1970) and susceptible to all common 
disinfectants (Scott, 1980). As an aerosol, it is relatively 
unstable at midrange and higher relative humidities (Donaldson 
and Ferris, 1976). 
Xnçidençe_and_çiÍQÍçal_si.gnsi 
FHV 1 is a highly successful virus in cats. It is 
widespread throughout the world (Crandell, 1973) and together 
with feline calicivirus, accounts for the majority of cases of 
feline respiratory disease (Kahn and Hoover, 1976; Gaskell and 
Wardley, 1978). Clinically it is the most significant of the 
feline respiratory pathogens. Serological surveys prior to 
vaccination demonstrated FHV 1 serum neutralising antibody 
titres in 26-70X of cats, depending on the nature of the sample 
population (Studdert and Martin, 1970; Povey and Johnson, 1971; 
Ellis, 1981). In general infection is less common in isolated 
household pets than in colony animals. However, the household 
pet is artificially separated from other cats by man; an open 
colony situation being a truer reflection of how virus and host 
evolved together. Once the virus has gained access to a 
susceptible colony, often by means of a clinically normal 
carrier, the disease rapidly becomes endemic, its presence 
being noted by the existence of chronically affected animals 
with recurrent or persistent signs. Outbreaks of acute disease 
may also occur, particularly in young kittens when they lose 
their passive immunity. 
Acute infection with FHV 1 is characterised by depression, 
sneezing and ocular and nasal discharges (Crandell et al., 
1961; Gaskell and Povey, 1979a). There is usually a fever and 
loss of appetite. Conjunctivitis, hypersalivation, and 
sometimes dyspnoea and coughing may develop and there may be a 
recurrence of the pyrexia. A leucocytosis with a left shift is 
present throughout the course of the disease. Other, rarer 
manifestations have been reviewed by Gaskell and Wardley (1978) 
and Povey (1979). Mortality may be high in young or debilitated 
cats and virus generalisation may occasionally occur. The 
majority of clinical signs have usually resolved in 10-20 days, 
but some animals may be left with chronic sequelae such as 
conjunctivitis, rhinitis, or sinusitis. These are probably 
mainly due to severe mucosal damage and secondary bacterial 
infection, but may also occur as a result of viral 
recrudescence. 
Ex.Eerimental_in£e^tiçm_and_indyc:tiçxi_of_re^exç 
The most common route of infection used experimentally is 
intranasal, although several other routes have been 
investigated (Povey, 1979). The incubation period is 2—7 days, 
though it may be longer and has been shown to be dose-related 
(Gaskell and Povey, 1979a). Virus is shed in oropharyngeal, 
nasal and conjunctival secretions for a period of one to three 
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weeks, titres of up to 10*··a (mean 10*) TCIDno per ml. o-f 
secretion being reached (Gaskell, 1975). 
Experimentally it has been shown that the majority of FHV 
1 recovered animals are latently infected virus carriers 
(Gaskell and Povey, 1973, 1977). Re-excretion may occur 
spontaneously, but is most likely to occur following stress. 
Under experimental conditions it has been shown that a change 
of housing may induce virus shedding in 187. of 22 FHV 1 
recovered cats on 157. occasions, and corticosteroid in 697. of 
32 cats on 54"/. occasions (Gaskell and Povey, 1973, 1977). 
Climatic stress appeared to be ineffective in inducing 
re—excretion. The apparently spontaneous shedding rate was 0.97. 
on any one day. In these studies, a total of 827. of FHV 1 
recovered cats shed endogenous virus on at least one occasion 
and 457. shed virus spontaneously or under "natural" stress 
conditions and thus could be considered epidemiological 1 y 
important. Similar findings have been reported by Ellis (1981) 
and Goddard (1984). 
A lag period occurred before onset of virus shedding of 
from 4—11 days (mean 7.2) after corticosteroid treatment, and 
from 4-10 days (mean 7.2) after re-housing (Gaskell and Povey, 
1973, 1977). The duration of virus shedding ranged from 1-13 
days (mean 6.5) after corticosteroid and 4—7 days (mean 7.2) 
after re-housing. Titres of virus shed were generally lower (p 
less than 0.01) than in the acute stage of the disease, 
although amounts of up to 10°-α (mean 103-1) TCID H O per ml. of 
secretion were recorded (Gaskell, 1975). In some cases (727. 
following corticosteroid stress, 307. following re-housing) 
shedding was accompanied by recrudescence of mild clinical 
signs, though occasionally signs were seen in carriers 
unassociated with detectable episodes of re—excretion. 
It appeared that there was a refractory period following 
an episode of corticosteroid induced re—excretion during which 
further administration of corticosteroid was less effective 
(Gaskell and Povey, 1977). Cats which did re-excrete as a 
result of treatment had last shed virus on an average of 16 
weeks before, whereas cats which did not re-excrete had 
experienced their last episode of virus shedding on an average 
of only eight weeks before (p less than 0.01). Considerable 
variation was apparent however, both within and between 
individuals. 
The site or sites of latency have not been completely 
elucidated for FHV 1. Despite several unsuccessful attempts in 
the past to isolate virus from the trigeminal ganglia and a 
number of other tissues of latently infected cats (Plummer et 
al., 1973; Gaskell and Povey, 1979b; Ellis, 1982), recently 
virus has been isolated using a tissue fragment culture 
technique from the trigeminal ganglia of a small proportion, 3 
(187.) of 17 recovered animals (Gaskell and Goddard, 1984; 
Gaskell et al., 198 5). However, it remains to be seen if this 
is the major or only site of viral persistence in this species. 
Natural _transiiiissign_gf_the_diseaseI_ 
The major method of spread of FHV 1 is by direct 
cat—to—cat contact, either from animals in the acute stage of 
the disease, or from shedding carriers. There is no evidence of 
vertical transmission. Indirect transmission may also occur, 
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but probably less frequently, and only within the close 
confines of a cattery. Carrier cats are of considerable 
epidemiological significance: they are widespread in the 
population, and in an endemic cattery, constitute the majority 
of recovered animals. In the field situation, surveys of 
clinical normal cats have shown an apparently spontaneous 
shedding rate of 1-27. (Wardley et al., 1974; Ellis, 1981), and 
Gaskell (1975) recorded FHV 1 re-excretion in 3 of 75 cats 9-12 
days after entering a boarding cattery. It seems probable, 
therefore, extrapolating from the experimental studies, that 
other stresses, such as going to stud, to a cat show, or 
entering a new cat colony, may also induce similar episodes of 
re—excretion. 
Although carriers are undoubtedly a source of infectious 
virus and can initiate outbreaks of disease, it seems that 
cross-infection is less easily achieved from a shedding carrier 
than from an acutely infected animal (Gaskell and Povey, 1982). 
Thus under experimental conditions, fairly intimate contact of 
several days' duration is necessary before successful 
transmission may occur. This is presumably because discharges 
are usually more copious and in slightly higher titre in 
acutely infected animals than in carriers. 
Under more natural conditions, however, it is likely that 
the greatest importance of the carrier lies in its ability to 
transmit the virus within the close contact of family groups, 
thus enabling it to perpetuate the host—virus relationship into 
the next generation. In studies on the possible transmission of 
FHV 1 from carrier queens to their kittens, the shedding rate 
from queens in the 10 week post—partum period did appear to be 
marginally increased above the spontaneous rate: four of ten 
queens re-excreted virus and four kittens from three litters 
developed a contact infection (Gaskell and Povey, 1982). None 
showed clinical signs and were presumably infected under cover 
of passive immunity. Two shed virus for one day only and did 
not become carriers, and two shed virus for two to three weeks 
and were subsequently shown to have become carriers: their SN 
antibody titres rising from less than 1 in 4 and 1 in 8 prior 
to re-excretion, to 1 in 96 and 1 in 128 after. The 
establishment of a latent carrier state under cover of passive 
immunity in animals which then became sero-negative, has also 
been shown for HSV infection in mice (Sekizawa et al., 1980). 
From other studies it appears that there are many cases 
where carrier queens shed virus either when their own or other 
kittens in close contact are unprotected by maternal antibody, 
and cases of acute disease result (Povey and Johnson, 1967; 
Crandell, 1971). Although such cases will aid viral 
dissemination in the short term, in many ways it is not a good 
method for the virus to perpetuate itself in its host as 
mortality and also chronic sequelae in young kittens can be 
high. The findings outlined above, however, show that on some 
occasions at least, the cat has an ideal method of perpetuating 
a balanced virus—host relationship which does not depend on the 
development of clinical disease. This then leads to the 
establishment in the next generation of the latent carrier 
state, so the cycle is complete. 
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I«eyne_çontrgl_gf_re—excretigQi -
Immunity to re-infection following primary infection with 
FHV 1 is not very complete or persistent; an animal may be 
re-infected within six months of a primary infection, although 
such cats show only mild clinical signs and a reduced period of 
virus shedding (Walton and Gillespie, 1970). A number of 
vaccines have been developed for use in controlling the 
disease, including live attenuated vaccines given intranasal 1 y 
or systemically, and inactivated vaccines given systemically. 
These have been reviewed elsewhere (Gaskell, 1981). All 
vaccines protect to a large extent against clinical signs 
following challenge, though the intranasal route may be 
marginally more effective. However it has been shown that 
following systemic vaccination, cats generally replicate virus 
for several days after challenge and may subsequently become 
latent field virus carriers (Orr et al-, 1978). Following 
intranasal vaccination, however, with a cold—adapted strain of 
FHV 1, virus replication after challenge appeared to be 
minimal, and in the short term at least, no animals appeared to 
have become carriers (Orr et al., 1980; Cocker et al., 19B4). 
Thus some vaccinated animals, whilst themselves protected from 
clinical disease, may still be a source to others of infectious 
field virus. 
Whether or not repeated vaccination helps control viral 
re—excretion episodes is not known. There appears to be a 
natural refractory period after an episode of re-excretion (see 
earlier) and so it seems possible that externally administered 
antigen may also help control re-excretion. 
PIGEON HERPESVIRUS 1 <PHV 1). 
PHV 1 is predominantly a respiratory pathogen of pigeons, 
although it also occurs in budgerigars and is antigenically 
indistinguishable from falcon or owl herpesviruses (Mare and 
Graham, 1973; Purchase et al., 1972). However it is probable 
that pigeons are the predominant natural host of PHV 1, and 
that infection in budgerigars, and possibly other species, is 
an epidemiological dead-end. Thus, although a spectrum of 
clinical signs may be seen in infected pigeons, in budgerigars, 
PHV 1 provokes, both naturally and experimentally, a fatal 
hepatitis (Vindevogel and Duchatel, 1977; Vindevogel et al., 
197B, 19B0C). 
A similar situation exists with Aujeszky's disease virus 
(ADV) (Suid herpesvirus 1) where pigs are the main host, and 
infection in other species, such as cattle, dogs and cats, is 
of no epidemiological significance (Aguilai—Setién et al., 
1979a, 1979b). 
Xnçidence_and_cl_iniçal_si.gnsí. 
PHV 1 infection is widespread in domestic pigeon 
populations. In Belgium, specific antibodies have been detected 
in the sera of 847. of clinically normal pigeons and 637. of 
pigeons affected with acute respiratory illness. PHV 1 has been 
isolated in 607. of dove-cots permanently affected with 
respiratory disease and from 825C of pigeons affected with acute 
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respiratory troubles (Vindevagel et al., 1981; Vindevogel and 
Duchatel, 1978). A similar situation has been described in 
Germany and France (Heffels et al., 1981; Landre et al., 1982). 
Virus has also been isolated from pigeons coming from dove-cots 
where all birds are devoid of detectable specific antibodies 
(Landre et al., 1982). 
Under natural conditions, clinical disease is 
predominantly seen in primary infection of young pigeons 
derived from parents free of the infection, or in carriers of 
the virus with the help of debilitating factors (Vindevogel et 
al., 1980a, 19B1). Experimental disease may be reliably 
produced in squabs born from virus—free parents (Vindevogel and 
Pastoret, 1981). 
Classical signs of PHV 1 infection in pigeons are 
conjunctivitis, rhinitis, and focal necrosis, in the mouth, 
pharynx and larynx. In some cases, particularly in pigeons 
weakened by debilitating factors such as parasitic disorders or 
secondary bacterial invaders, viral dissemination may also 
occur and lesions may be observed in liver, spleen, kidney and 
pancreas (Cornwell and Wright, 1970; Boyle and Binnington, 
1973; Vindevogel et al., 1975; Vindevogel and Pastoret, 1981). 
ExEectfSeDtai-iOÍeEÊigD-stía-iDdyEÈÍgO-gf-re^exçretigni 
After inoculation with PHV 1 by pharyngeal painting, 
susceptible squabs excrete virus for a minimum of 7 to 10 days 
(Vindevogel et al., 1980b). The typical lesions appear 1 to 3 
days after infection when the viral excretion reaches its 
highest titre. Virus usually remains confined near the site of 
inoculation, although viraemia may occur. 
Mild episodes of recurrence, without clinical signs, occur 
spontaneously (Vindevogel et al., 1980b). High titres of 
specific antibodies do not prevent these recurrences, and 
conversely, recurrent episodes do not occur more frequently 
when the animals are nearly devoid of specific antibodies. 
PHV 1 re-excretion can be provoked experimentally by 
cyclophosphamide (Cy) treatment, and this period of 
re—excretion may be accompanied by lesions of varying severity 
and some birds may die (Vindevogel et al., 1980b; Vindevogel 
and Pastoret, 1981). In one group, all birds re-excreted 
infectious virus starting 2 to 5 days after the first injection 
of Cy for between 1 to 10 days: amounts of virus shed were 
similar to those seen in the acute phase of the disease. The 
mechanism by which Cy initiates viral re-excretion is not 
known. It may be due to a direct cytotoxic effect on latently 
infected cells or indirectly through the effects, of Cy on B and 
T lymphocytes (Coignoul and Vindevogel, 1980). This effect of 
Cy on the immune system may account for the more severe 
clinical syndrome and higher mortality seen in Cy treated birds 
(Vindevogel et al., 1980b; Vindevagel and Pastaret, 1981). 
Natural _transmissi_gn_gf_the_diseasei As far as is known, egg transmission of the disease does 
not occur. No genital form of the disease has been detected and 
neither virus nor its antigen could be demonstratred in cell 
cultures derived from embryos from infected parents (Vindevogel 
and Pastoret, 1980, 1981). 
Although virus may be spread horizontally from acutely 
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infected birds, infection is mainly perpetuated by means of 
carriers. Thus in a flock of pigeons infected with PHV 1, 
virtually all the mature birds are asymptomatic carriers of the 
virus and are thus a potential source of infection to their 
offspring, and to any susceptible in-coming birds. Apparently 
spontaneous episodes of re—excretion may occur, and since 
significant amounts of virus are shed, such birds presumably 
may transmit the infection (Vindevogel et al., 1980b). However 
there is some evidence that these spontaneous episodes are not 
as long-lasting as Cy-induced or natural stress-induced 
episodes of re-excretion, and thus they may not be of such 
epidemiological significance. 
Studies have shown however, that virtually all pigeons 
will experience an asymptomatic re-excretion episode of 
reasonable duration during the reproductive period. Most of 
them re—excrete virus soon after the hatching period, when they 
regurgitate "milk" for their squabs (Vindevogel et al., 19B5). 
After weaning (12th week after hatching) all parents cease 
shedding virus. The squabs become infected but are protected 
from the disease by passive immunity of parental origin, 
conferred to the squabs through the egg yolk. Most of the 
squabs themselves then become asymptomatic carriers after this 
initial infection, though they are very soon devoid of 
detectable antibodies. However, infection may be unmasked by Cy 
treatment, and presumably such squabs may themselves be capable 
subsequently of transmitting the virus to the next generation. 
Under natural conditions therefore, there is a 
sophisticated equilibrium between the virus and its host that 
prevents the occurrence of disease. Nearly all the birds are 
infected and the infection can be perpetuated with a small 
number of infected birds, without exogenous introduction of 
wild virus. 
Xmmune_çgntrgl._gf _re-excretigni 
Primary infection of pigeons with a pathogenic strain of 
PHV 1 (Vindevogel et al-, 1982) prevents recurrence of the 
disease after re-infection. The protection is sufficient to 
inhibit viral multiplication in some birds. Both attenuated and 
oi1-adjuvanted inactivated vaccines have been developed and are 
effective in reducing primary viral excretion and symptoms 
after challenge (Vindevogel et al., 1982a and b ) . Nevertheless 
neither vaccine was able to prevent the appearance of carriers 
since most of the pigeons subsequently re-excreted virus after 
Cy treatment. However vaccination helps to prevent spontaneous 
viral re-excretion and therefore helps to control viral 
dissemination. If animals are vaccinated with an inactivated 
vaccine after challenge with a virulent strain, experimental 
re-excretion is also reduced. 
Nevertheless, vaccination is not the complete answer for 
the control of PHV infection, since young pigeons are often 
infected shortly after hatching and vaccination does not 
prevent the development of a carrier state or subsequent 
episodes of re-excretion. 
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DISCUSSION. 
These animal-herpesvirus systems demonstrate the 
phenomenon of latency in the natural host. In each system, 
well—defined re—excretion episodes may be provoked by means of 
artificial stimuli such as corticosteroid or cyclophosphamide. 
In addition, re-excretion episodes may also be stimulated by 
means of natural stresses such as reproduction or a change of 
housing. 
There are several advantages to using natural host—virus 
systems to study the phenomenon of herpesvirus latency. 
Firstly, since virus and host probably evolved together over a 
considerable period, the biological and epidemiological 
significance of spontaneous and natural shedding episodes may 
be assessed. In addition, observations on the mechanism of 
establishing, maintaining reactivating, and controlling latency 
are probably more valid since they also relate to a naturally 
evolved relationship. In contrast, laboratory models such as 
the mouse—HSV system are easier and cheaper to maintain and are 
better defined genetically and immunologically. 
To be a successful parasite, a virus needs to be able to 
ensure its transmission to as many animals as possible in each 
generation. Herpesviruses are in general relatively fragile 
outside their host, and therefore they cannot rely on external 
survival for their long—term persistence. In general, they have 
no reservoir or alternative hosts. Transmission by direct 
contact spread from acutely infected to susceptible animals 
certainly occurs, but requires a sufficient number of 
susceptible animals in the population and sufficient 
opportunities for contact between them or the virus will die 
out. Herpesviruses have there evolved the highly successful 
method of perpetuating themselves in a population by means of 
latently-infected carriers. Such carriers are only of 
biological significance, however, if shedding episodes coincide 
with the presence of susceptible individuals in close enough 
contact for transmission to occur. 
In a population where the disease is endemic, the time 
when this is most likely to occur is just before or during 
weaning when the parent and young are still in very close 
contact but the young have become susceptible to the virus due 
to the waning of passive antibody. 
Studies on the cat and pigeons have shown however that the 
timing of the shedding episode during this post—partum period 
is crucial. If it is too soon, only transient infection will 
occur and the offspring might not themselves become carriers. 
If it is too late, i.e. when maternal antibody has completely 
waned, then the clinical disease may be too severe and the 
host's survival compromised. Ideally the shedding, episode 
should occur whilst the offspring are still protected from 
clinical disease, but not from virus shedding and the 
subsequent development of a latent carrier state. In the pigeon 
particularly, but to a lesser extent also in the cat, such a 
balanced virus-host relationship does occur, ensuring survival 
of the virus in as many animals as possible in the next 
generation, so that the cycle is complete. Indeed it may be 
that even in the cat, under more natural conditions, shedding 
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may occur in more animals during the post-partum period than 
was apparent from these studies: the cats used in this work had 
previously been induced to shed artificially on a number of 
occasions, and this may have induced a relative "refractory 
period", making them less likely to shed after parturition. 
In a herd or family group, where the young are of similar 
age and are in reasonably close contact, not all the parents 
need to re-excrete to ensure virus transmission to all the 
offspring. Once one clinical case has occurred, virus 
dissemination will be greatly increased. Nevertheless, such a 
system, which tends to be seen particularly in cat colonies, is 
not ideal, since the timing of shedding in relation to the 
presence or absence of maternal antibody may be less than 
perfect. Severe clinical disease may then ensue and mortality 
and chronic sequelae may be significant, thus jeopardizing the 
host's and therefore the virus's survival into the next 
generation. 
Another useful tool for the virus epidemiologically is the 
increased likelihood of shedding after a change in living 
conditions, a situation which has been demonstrated 
particularly in cats. Thus if an animal is driven from its 
territory or family group, then it is likely to re-excrete 
virus in its new surroundings and may therefore infect another 
population. By this means the virus has a mechanism for 
increasing its chances of horizontal spread. 
In conclusion, observations on natural host-virus systems 
may tell us more about the biological significance of latency, 
and indeed, more about the host-virus relationship in general. 
Perhaps if most natural infections occur in young animals when 
they are losing their passive immunity, this should be the age 
at which both the mechanisms for establishing and controlling 
latency should be examined. It should be interesting to compare 
the frequency of recrudescent disease in people or animals that 
have experienced asymptomatic primary infection at an early age 
under cover of passive immunity, with those who experienced 
later symptomatic infections. Finally perhaps hormone 
influences on re-excretion rates and recrudescent disease 
should be examined in more detail. 
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